| 摘要 |
A method and apparatus for early detection and treatment of abnormal biological activity by specific, localized therapeutic response based on biomarker detection to minimize levels of administrated drugs and reducing toxicity. An external communication device communicates with an implanted probe calibrated to detect a biomarker and an implanted therapeutic delivery system.
|
